168 related articles for article (PubMed ID: 34238197)
1. Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-Based Systems for Effective Management of Lung Cancer.
Fatima M; Iqubal MK; Iqubal A; Kaur H; Gilani SJ; Rahman MH; Ahmadi A; Rizwanullah M
Anticancer Agents Med Chem; 2022; 22(4):668-686. PubMed ID: 34238197
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
3. Etiology of lung carcinoma and treatment through medicinal plants, marine plants and green synthesized nanoparticles: A comprehensive review.
Chaudhary P; Janmeda P; Pareek A; Chuturgoon AA; Sharma R; Pareek A
Biomed Pharmacother; 2024 Apr; 173():116294. PubMed ID: 38401516
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
[TBL] [Abstract][Full Text] [Related]
8. Himalayan flora: targeting various molecular pathways in lung cancer.
James A; Akash K; Sharma A; Bhattacharyya S; Sriamornsak P; Nagraik R; Kumar D
Med Oncol; 2023 Oct; 40(11):314. PubMed ID: 37787816
[TBL] [Abstract][Full Text] [Related]
9. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy.
Ganesan P; Choi DK
Int J Nanomedicine; 2016; 11():1987-2007. PubMed ID: 27274231
[TBL] [Abstract][Full Text] [Related]
10. New Avenues and Major Achievements in Phytocompounds Research for Glioblastoma Therapy.
Majchrzak-Celińska A; Studzińska-Sroka E
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611962
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade.
Melim C; Magalhães M; Santos AC; Campos EJ; Cabral C
Expert Opin Drug Deliv; 2022 Feb; 19(2):179-197. PubMed ID: 35166619
[TBL] [Abstract][Full Text] [Related]
12. Cosmeceuticals: Nanotechnology-Based Strategies for the Delivery of Phytocompounds.
Puglia C; Santonocito D
Curr Pharm Des; 2019; 25(21):2314-2322. PubMed ID: 31584366
[TBL] [Abstract][Full Text] [Related]
13. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.
Pistollato F; Bremer-Hoffmann S; Basso G; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M
Target Oncol; 2016 Feb; 11(1):1-16. PubMed ID: 26275397
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lung cancer using nanoparticle drug delivery systems.
Chandolu V; Dass CR
Curr Drug Discov Technol; 2013 Jun; 10(2):170-6. PubMed ID: 23363233
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy.
Wang W; Hao Y; Liu Y; Li R; Huang DB; Pan YY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1654. PubMed ID: 32700465
[TBL] [Abstract][Full Text] [Related]
17. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems.
Cao H; Li X; Wang F; Zhang Y; Xiong Y; Yang Q
Curr Med Chem; 2020; 27(4):599-629. PubMed ID: 31400262
[TBL] [Abstract][Full Text] [Related]
18. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
Amreddy N; Babu A; Panneerselvam J; Srivastava A; Muralidharan R; Chen A; Zhao YD; Munshi A; Ramesh R
Nanomedicine; 2018 Feb; 14(2):373-384. PubMed ID: 29155362
[TBL] [Abstract][Full Text] [Related]
19. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations.
Sartaj A; Qamar Z; Qizilbash FF; Annu ; Md S; Alhakamy NA; Baboota S; Ali J
Polymers (Basel); 2021 Dec; 13(24):. PubMed ID: 34960948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
